日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Switching Therapy to the Second Brand of Generic Atorvastatin: A 6-Month Retrospective Cohort, Real-World Study

将治疗方案切换至第二种品牌的阿托伐他汀仿制药：一项为期 6 个月的回顾性队列真实世界研究

期刊:Drugs-Real World Outcomes
影响因子:1.9
doi:10.1007/s40801-025-00491-0
Manasirisuk, Panisa; Tiamkao, Somsak; Wongvipaporn, Chaiyasith; Chainirun, Nanthaphan; Sawanyawisuth, Kittisak
发表日期：2025
文献求助 收藏

Efficacy of Generic Atorvastatin in a Real-World Setting

仿制阿托伐他汀在真实世界中的疗效

期刊:Clinical Pharmacology-Advances and Applications
影响因子:2.5
doi:10.2147/CPAA.S285750
Manasirisuk, Panisa; Chainirun, Nanthaphan; Tiamkao, Somsak; Lertsinudom, Sunee; Phunikhom, Kutcharin; Sawunyavisuth, Bundit; Sawanyawisuth, Kittisak
发表日期：2021
文献求助 收藏

The Efficacy and Safety Profile of Generic Intravenous Levetiracetam in a Real-World Setting

真实世界中通用静脉注射左乙拉西坦的疗效和安全性概况

期刊:Current Therapeutic Research-Clinical and Experimental
影响因子:1.5
doi:10.1016/j.curtheres.2021.100648
Ruangritkul, Preechaya; Tiamkao, Siriporn; Chainirun, Nanthaphan; Pranboon, Sineenard; Tiamkao, Somsak; Sawanyawisuth, Kittisak; Khamsai, Sittichai
发表日期：2021
文献求助 收藏

The PAPHIO study protocol: a randomised controlled trial with a 2 x 2 crossover design of physical activity adherence, psychological health and immunological outcomes in breast cancer survivors

PAPHIO 研究方案：一项采用 2 x 2 交叉设计的随机对照试验，研究乳腺癌幸存者的身体活动依从性、心理健康和免疫学结果

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-020-08827-x
Pudkasam, Supa; Pitcher, Meron; Fisher, Melanie; O'Connor, Anne; Chinlumprasert, Nanthaphan; Stojanovska, Lily; Polman, Remco; Apostolopoulos, Vasso
肿瘤免疫
肿瘤
乳腺癌
免疫/内分泌
发表日期：2020
文献求助 收藏